# Neuropathy and Anti-GFAP Antibodies

> **NCT05742087** · — · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 120 (estimated)

## Conditions studied

- Neurological Diseases or Conditions
- Neurological Diseases Associated to Anti GFAP Antibodies

## Interventions

- **OTHER:** Clinical examination
- **OTHER:** electroneuromyography (ENMG)

## Key facts

- **NCT ID:** NCT05742087
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-01
- **Primary completion:** 2022-10-01
- **Final completion:** 2023-05-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05742087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05742087, "Neuropathy and Anti-GFAP Antibodies". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05742087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*